Tumor-only genetic sequencing may misguide cancer treatment in nearly half of all patients, study shows

A study strongly suggests that sequencing tumor genomes for clues to genetic changes might misdirect treatment in nearly half of all patients unless it is compared first to a genetic readout of their noncancerous tissue.



from Today's Healthcare News -- ScienceDaily http://ift.tt/1bhLD4q